查找临床试验

已按「脂肪肝」检索,对应国际通用词 metabolic dysfunction-associated steatohepatitis

试验不在中国怎么办?

共找到 12 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 10:03,每 5 分钟自动同步
正在招募不适用中国有中心NCT07070362

Digital Early Warning System for Acute Lung Injury in Liver Surgery

China

年龄 18 Years不限

Beijing Tsinghua Chang Gung Hospital

正在招募III 期中国有中心NCT07221227

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

United States、Australia、Canada、Hong Kong、Japan 等 9 国

年龄 18 Years75 Years

GlaxoSmithKline

正在招募III 期中国有中心NCT06419374

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

United States、Argentina、Australia、Belgium、Brazil 等 12 国

年龄 18 Years75 Years

89bio, Inc.

正在招募II 期中国有中心NCT07145151

A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

China

年龄 18 Years75 Years

The United Bio-Technology (Hengqin) Co., Ltd.

正在招募不适用中国有中心NCT07083336

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

China

年龄 18 Years不限

State Key Laboratory of Subhealth Intervention Technology

正在招募不适用中国有中心NCT07632677

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

China

年龄 18 Years不限

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

正在招募不适用中国有中心NCT07241195

A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes

China

年龄 65 Years100 Years

The Affiliated Hospital of Hangzhou Normal University

正在招募III 期中国有中心NCT06632444

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

United States、Argentina、Australia、Austria、Belgium 等 12 国

年龄 18 Years不限

Boehringer Ingelheim

正在招募不适用中国有中心NCT05974904

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

China

年龄 18 Years90 Years

Chongqing Medical University

正在招募III 期中国有中心NCT06318169

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

United States、Argentina、Australia、Austria、Belgium 等 12 国

年龄 18 Years80 Years

89bio, Inc.

正在招募II 期中国有中心NCT06937749

A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

China

年龄 18 Years不限

Innovent Biologics (Suzhou) Co. Ltd.

正在招募不适用中国有中心NCT06939569

An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

China

年龄 18 Years不限

Shanghai East Hospital